Secukinumab
Therapeutic Group
ImmunosuppressantsIndication Dosage
Psoriatic Arthritis, Ankylosing Spondylitis:
By Sc Inj:
- Adult: 150 Mg Every Week For 5 Doses, Then Maintenance 150 Mg Every Month, Review Treatment If No Response Within 16 Weeks
Psoriatic Arthritis With Concomitant Moderate To Severe Plaque Psoriasis Or If Inadequate Response To Anti-tonfa Treatment, Plaque Psoriasis:
By Sc Inj:
- Adult: 300 Mg Every Week For 5 Doses, Then Maintenance 300 Mg Every Month, Review Treatment If No Response Within 16 Weeks
Content
- Inj 150mg: Secukinumab150mg, Lyophilized Powder In A Single-use Vial For Reconstitution
Pregnancy
Avoid In Pregnancy
Stability
- Immunosuppressants
- Recombinant Human Monoclonal Interleukin-17a (il-17a) Antagonist
Contra Indications
- Severe Active Infection, Serious Hypersensitivity Reaction.
Precautions
- Severe Active Infection, Serious Hypersensitivity Reaction.
Lactation
- Avoid During Treatment and for up to 20 Weeks After Discontinuing Treatment
Side Effects
- Upper Respiratory Tract Infections
- Diarrhoea
- Oral Herpes
- Rhinorrhoea
- Conjunctivitis . Neutropenia (mild And Reversible)
- Oral Candidiasis
- Otitis Externa
- Tinea Pedis
- Exacerbations Of Inflammatory Bowel Disease.
- Rare: Anaphylactic Reactions Or Other Serious Allergic Reaction And Cases Of Urticaria